In line with this, genetically increasing or decreasing the expression of PM20D1 reduced and aggravated AD-related pathologies, respectively, thus suggesting that in a particular genetic background, PM20D1 contributes to neuroprotection against AD [72]. Here, PM20D1 is linked to Alzheimer disease.